3rd Circ. Won't Rethink Lamictal Pay-For-Delay Ruling
The Third Circuit on Wednesday refused to reconsider, either by a panel or en banc, a ruling reviving an antitrust class action claiming GlaxoSmithKline PLC paid off Teva Pharmaceutical Industries Ltd....To view the full article, register now.
Already a subscriber? Click here to view full article